Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert F Storey

Showing results (271-280 of 401) with videos related to

Pageof 41
Sort By:
Thrombosis and Haemostasis|August 18, 2019
Thrombogenicity and Antithrombotic Strategies in Structural Heart Interventions and Nonaortic Cardiac Device Therapy-Current Evidence and PracticeTobias Geisler, Rezo Jorbenadze, Aron-Frederik Popov, et al.
Giornale Italiano Di Cardiologia (2006)|March 8, 2012
[ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)]Christian W Hamm, Jean-Pierre Bassand, Stefan Agewall, et al.
Lancet (London, England)|January 19, 2010
Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind studyChristopher P Cannon, Robert A Harrington, Stefan James, et al.
Plos One|April 21, 2010
Stabilizing role of platelet P2Y(12) receptors in shear-dependent thrombus formation on ruptured plaquesReyhan Nergiz-Unal, Judith M E M Cosemans, Marion A H Feijge, et al.
European Heart Journal|August 30, 2011
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)Christian W Hamm, Jean-Pierre Bassand, Stefan Agewall, et al.
The Journal of Clinical Endocrinology and Metabolism|September 26, 2018
Effect of Hypoglycemia on Inflammatory Responses and the Response to Low-Dose Endotoxemia in HumansAhmed Iqbal, Lynne R Prince, Peter Novodvorsky, et al.
European Heart Journal|December 26, 2015
Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on ThrombosisAlexander Niessner, Juan Tamargo, João Morais, et al.
Journal of the American College of Cardiology|March 12, 2016
Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 TrialRobert F Storey, Dominick J Angiolillo, Marc P Bonaca, et al.
European Heart Journal|November 18, 2011
Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trialRichard C Becker, Jean Pierre Bassand, Andrzej Budaj, et al.
Circulation|January 21, 2012
Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trialShaun G Goodman, Robert Clare, Karen S Pieper, et al.
Pageof 41

Showing results (271-280 of 401) with videos related to

Sort By:
Pageof 41
Thrombosis and Haemostasis|August 18, 2019
Thrombogenicity and Antithrombotic Strategies in Structural Heart Interventions and Nonaortic Cardiac Device Therapy-Current Evidence and PracticeTobias Geisler, Rezo Jorbenadze, Aron-Frederik Popov, et al.
Giornale Italiano Di Cardiologia (2006)|March 8, 2012
[ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)]Christian W Hamm, Jean-Pierre Bassand, Stefan Agewall, et al.
Lancet (London, England)|January 19, 2010
Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind studyChristopher P Cannon, Robert A Harrington, Stefan James, et al.
Plos One|April 21, 2010
Stabilizing role of platelet P2Y(12) receptors in shear-dependent thrombus formation on ruptured plaquesReyhan Nergiz-Unal, Judith M E M Cosemans, Marion A H Feijge, et al.
European Heart Journal|August 30, 2011
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)Christian W Hamm, Jean-Pierre Bassand, Stefan Agewall, et al.
The Journal of Clinical Endocrinology and Metabolism|September 26, 2018
Effect of Hypoglycemia on Inflammatory Responses and the Response to Low-Dose Endotoxemia in HumansAhmed Iqbal, Lynne R Prince, Peter Novodvorsky, et al.
European Heart Journal|December 26, 2015
Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on ThrombosisAlexander Niessner, Juan Tamargo, João Morais, et al.
Journal of the American College of Cardiology|March 12, 2016
Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 TrialRobert F Storey, Dominick J Angiolillo, Marc P Bonaca, et al.
European Heart Journal|November 18, 2011
Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trialRichard C Becker, Jean Pierre Bassand, Andrzej Budaj, et al.
Circulation|January 21, 2012
Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trialShaun G Goodman, Robert Clare, Karen S Pieper, et al.
Pageof 41